Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors

Leukemia

Volumn 12, Issue 11, 1998, Pages 1708-1717

  Bhatia, R ^a   Munthe, H A ^a   Verfaillie, C M ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

BCR ABL; Chronic myelogenous leukemia; Hematopoiesis; Integrins; Tyrosine kinase

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CYTOKINE RECEPTOR; CYTOSKELETON PROTEIN; HLA DR ANTIGEN; INTEGRIN; PROTEIN TYROSINE KINASE INHIBITOR; SIGNAL PEPTIDE; TYRPHOSTIN;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STROMA;

EID: 0031752846     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401193     Document Type: Article

References (18)

1. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukaemia. Nature 1984; 328: 342-344.
2. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 1986; 83: 5306-5310.
3. hi stem cells to bone marrow stroma. J Clin Invest 1992; 90: 358-367.
4. Verfaillie CM, McCarthy JB, McGlave PB. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their adhesion to fibronectin. J Exp Med 1991; 174: 693-703.
5. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in hematopoietic stem cell-microenvironment interactions. Nature 1991; 352: 438-441.
6. Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lympho-hemopoeisis. J Exp Med 1991; 173: 599-607.
7. Hurley RW, McCarthy JB, Verfaillie CM. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 1995; 96: 511-519.
8. Verfaillie CM, Catanzaro P. Direct contact with stroma inhibits proliferation of human long-term culture initiating cells. Leukemia 1996; 10: 498-504.
9. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 1992; 90: 1232-1239.
10. Bhatia R, McCarthy JB, Verfaillie CM. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia. Blood 1996; 87: 3883-3891.
11. Rowley JD. A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 209-213.
12. DeKlein A, Van Kessel AG, Grosveld G et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1982; 300: 765-767.
13. Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic leukemia-specific P210 bcr/abl protein. Proc Natl Acad Sci USA 1988; 85: 9312-9316.
14. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the p210 bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824-827.
15. Wang JYJ. Abl tyrosine kinase in signal transduction and cell cycle regulation. Curr Opin Gen Dev 1993; 3: 35-43.
16. Lugo T, Pendergast A, Muller A, Witte O. Tyrosine kinase activity and transformation potency of bcr/abl oncogene products. Science 1990; 237: 1079-1082.
17. BCR/ABL. Oncogene 1995; 11: 1149-1155.
18. BCR/ABL. J Biol Chem 1995; 270: 5039-5047.